4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-21-025456
Chief Operating Officer sold 14,500 shares at an average $36.63 ($531,102)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nabulsi Azmi Chief Operating Officer | 2021-04-01 | Sale | −3,405 | $37.28 | $126,927 | 791,295 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-04-01 | Sale | −1,742 | $38.14 | $66,442 | 789,553 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-04-05 | Sale | −4,252 | $35.66 | $151,645 | 785,301 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-04-05 | Sale | −4,316 | $36.37 | $156,954 | 780,985 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-04-05 | Sale | −785 | $37.11 | $29,134 | 780,200 | I |
| Open-market sales · 14,500 sh · avg $36.63 · $531,102 | |||||||
Loading xslF345X03/doc4.xml…